Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.96 Analyst target: $8.25 Upside: 178.72%
OncoCyte Corporation is a precision diagnostics company in the United States and internationally. The company is headquartered in Irvine, California.
See the full interactive analysis & chart →Informational only — not investment advice.